Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$35.53 - $43.8 $2.13 Million - $2.63 Million
-60,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$27.84 - $38.92 $1.67 Million - $2.34 Million
60,000 New
60,000 $8.99 Million
Q1 2019

May 15, 2019

SELL
$28.07 - $38.18 $104,785 - $142,525
-3,733 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $100,753 - $139,502
3,733 New
3,733 $442,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.